Skip to main content
. Author manuscript; available in PMC: 2012 Sep 22.
Published in final edited form as: Adv Mater. 2011 Aug 15;23(36):H217–H247. doi: 10.1002/adma.201102313

Figure 5.

Figure 5

Targeting strategies to improve NP delivery throughout the tumor. I) Non-PEGylated NPs accumulate in the tumor site through the EPR effect. II) PEGylated NPs show enhanced accumulation in the tumor site through the EPR effect. III) Targeted NPs show better distribution throughout the tumor and higher cellular uptake. IV) Subcellular targeting increases NP delivery to the intracellular site of action of the drug.